Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macugen for Histoplasmosis-An Open-Label, Single-Site, Comparative, Prospective Case Series

NCT00272766 is registered in ClinicalTrials.gov with Barnes Retina Institute as lead sponsor.

NCT NCT00272766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macugen for Histoplasmosis-An Open-Label, Single-Site, Comparative, Prospective Case Series
Lead sponsor
Barnes Retina Institute
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2006
Completion date
May 31, 2007
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascularization, ocular histoplasmosis